ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P TSX Capped Composite...
42.45
-0.16%
US Tech 100
21,044.40
-0.54%
S&P 500
5,964.19
-0.28%
US Dollar vs CAD
1.373
0.24%
Bitcoin
103,315.00
-1.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Anavex Life Sciences Corporation (AVXL) Share Price

Anavex Life Sciences Corporation

Anavex Life Sciences Corporation (AVXL)

NASDAQ
9.09
0.06
( 0.66% )
Updated: 14:38:11
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
9.09
Bid
9.08
Ask
9.10
Volume
571,199
8.81 Day's Range 9.30
3.76 52 Week Range 14.4405
Market Cap
776.03M
Previous Close
9.03
Open
9.17
Last Trade
10
@
9.1
Last Trade Time
14:38:13
Financial Volume
US$ 5,182,920
VWAP
9.0738
Average Volume (3m)
924,881
Shares Outstanding
85,371,852
Dividend Yield
-
PE Ratio
-17.83
Earnings Per Share (EPS)
-0.5
Revenue
-
Net Profit
-43M

About Anavex Life Sciences Corporation

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are u... Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.anavex.com
Headquarters
Carson City, Nevada, USA
Founded
-
Anavex Life Sciences Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker AVXL. The last closing price for Anavex Life Sciences was US$9.03. Over the last year, Anavex Life Sciences shares have traded in a share price range of US$ 3.76 to US$ 14.4405.

Anavex Life Sciences currently has 85,371,852 shares outstanding. The market capitalization of Anavex Life Sciences is US$770.91 million. Anavex Life Sciences has a price to earnings ratio (PE ratio) of -17.83.

Ask ADVFN Intelligence (AI)

AVXL Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 13 2025
AVXL (0.66%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 09 2025
AVXL (0.66%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 13 2025
AVXL (0.66%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
April 30 2025
AVXL (0.66%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 25 2025
AVXL (0.66%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.0412.91925465848.059.357.977346328.72410715CS
41.621.36181575437.499.357.267780807.98680184CS
12-0.38-4.012671594519.479.87.169248818.33410077CS
260.556.440281030448.5414.44057.1612792299.57757752CS
525.24136.1038961043.8514.44053.7611923498.24943835CS
1560.343.885714285718.7515.243.2512052598.28426172CS
2603.9576.84824902725.1431.53.25135907810.89858128CS

AVXL - Frequently Asked Questions (FAQ)

What is the current Anavex Life Sciences share price?
The current share price of Anavex Life Sciences is US$ 9.09
How many Anavex Life Sciences shares are in issue?
Anavex Life Sciences has 85,371,852 shares in issue
What is the market cap of Anavex Life Sciences?
The market capitalisation of Anavex Life Sciences is USD 770.91M
What is the 1 year trading range for Anavex Life Sciences share price?
Anavex Life Sciences has traded in the range of US$ 3.76 to US$ 14.4405 during the past year
What is the PE ratio of Anavex Life Sciences?
The price to earnings ratio of Anavex Life Sciences is -17.83
What is the reporting currency for Anavex Life Sciences?
Anavex Life Sciences reports financial results in USD
What is the latest annual profit for Anavex Life Sciences?
The latest annual profit of Anavex Life Sciences is USD -43M
What is the registered address of Anavex Life Sciences?
The registered address for Anavex Life Sciences is 701 S CARSON ST, STE 200, CARSON CITY, NEVADA, 89701
What is the Anavex Life Sciences website address?
The website address for Anavex Life Sciences is www.anavex.com
Which industry sector does Anavex Life Sciences operate in?
Anavex Life Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WHLRWheeler Real Estate Investment Trust Inc
US$ 7.198
(110.47%)
50.63M
CTORCitius Oncology Inc
US$ 3.13
(101.94%)
14.91M
LGCLLucas GC Ltd
US$ 1.0411
(53.22%)
9.03M
INLFINLIF Limited
US$ 1.34
(48.41%)
57.92M
LUCYInnovative Eyewear Inc
US$ 3.38
(48.25%)
108.34M
NWGLNature Wood Group Ltd
US$ 1.67
(-70.34%)
3.71M
ICUSeaStar Medical Holding Corporation
US$ 0.3602
(-63.11%)
19.95M
MBRXMoleculin Biotech Inc
US$ 0.2794
(-52.08%)
14.01M
RGCRegencell Bioscience Holdings Ltd
US$ 35.10
(-44.59%)
1.98M
CGTLCreative Global Technology Holdings Ltd
US$ 1.45
(-36.12%)
6.51M
HCTIHealthcare Triangle Inc
US$ 0.028
(5.66%)
543.65M
DFLIDragonfly Energy Holdings Corporation
US$ 0.2496
(14.50%)
323.35M
GNLNGreenlane Holdings Inc
US$ 0.009101
(-12.07%)
219.93M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12.36
(-0.08%)
177.05M
NVDANVIDIA Corporation
US$ 143.895
(-1.09%)
168M

AVXL Discussion

View Posts
georgejjl georgejjl 10 minutes ago
The upward rise in AVXL stock into the close has started!!

Good luck and GOD bless,
👍️0
Jsgribbs Jsgribbs 25 minutes ago
Expect to ligma
👍️0
sab63090 sab63090 50 minutes ago
Citrati:
I looked through my thick files and found part of what I had on this concept since I couldn't find the ending page, basically saw an article in Technical Analysis of Stocks & Commodities (June 2020) using the Hammer and "confirming indicator" (MACD)..(if MACD confirms, it not forget)....article Hammer and MACD Pivots by Ken Calhoun.....also ModernTrader.com Issue 541 by Robb Ross March 2018 (Techniques & Tactics)...shooting star.........anyway, we'll see how this work itself out! Best, Steve
👍️ 1
georgejjl georgejjl 1 hour ago
The price of AVXL should resume the rise into the close soon!!!

Expect well over a million shares bought by or before the close of trading today.

Good luck and GOD bless,
👍️0
LakeshoreLeo1953 LakeshoreLeo1953 2 hours ago
Did you just finish watching Annie?
👺 1 🙏 1
Citrati Citrati 2 hours ago
Thanks for the info post and discussion Steve.

Green Trades.
👍️ 1
sab63090 sab63090 2 hours ago
Yes, the history of the stock is worth paying attention to! Most here have been around since 2015 so I have to respect what they and you have observed over a much longer time frame...
👍️ 1
BIOChecker4 BIOChecker4 2 hours ago
Expect AVXL to close at or near the low of the day on no anticipation of meaningful news anytime soon.
👎️ 1 👺 1
Citrati Citrati 2 hours ago
While I agree with your info in general I am reminded that all signals require confirmation. Another aspect is that individual stocks can have individually unique patterns of which AVXL seems to do a reversal/fade when the inverted hammer spike occurs outside the upper BB. In addition the issue is being faced again while in a strong support/resistance zone. Price could continue up for a variety of reasons. Combined with overbought and oversold momentum and trend indicators on the daily and volume still under 1million shares any additional upward movement is likely to be relatively small IMO unless there is some sector action of news that brings in stronger volume. The close today and closes first part of next week should give additional directional data. For example if todays close is below yesterdays close then adds a little to the down side. We also can't yet rule out sideways movement between 8.90 and 8.46.

What do we know for sure at 1:48 ET? Price has not made up its mind to go up more, down or sideways. There is information one can use to to say any one of those, but it would not be confirmed. What is definitive is that we are dealing with a major daily support/resistance zone.
👍️ 1
sab63090 sab63090 2 hours ago
Index Rebalancing is part of this quarterly option expiration....no longer get information on that stuff though! Good luck with tonight's late blast into the close......🤠
👍️0
sab63090 sab63090 3 hours ago
BDR

The open interest in the 8s is 506 contracts, the open interest in the 9s is 1504.....the mm will try to keep it just a tad below 9....I think this is the last weekly series, so now we'll just have the monthly expiration to focus on.....we are close enough to 9 to cause a little pressure with the effort to kill the calls....why worry?
👍️0
mike_dotcom mike_dotcom 3 hours ago
Wake up George, tomorrow is Saturday.
👍️0
k9uwa k9uwa 3 hours ago
Today is triple witching Day. So yes for sure. They tried a bit earlier to push us down farther. Probably also some calls at $8 I doubt they try for that one. If they get toward if I have a couple stink bids in as I will be off to golf course shortly. Fun to watch the MM's being pissed is excellent. Trades light 344K shares.

And yes Steve maybe we are around 20 by then.. Missling could keep 2/3rds in cashless transaction.

GLTAL

John k9uwa
👍️0
georgejjl georgejjl 3 hours ago
SOON!!!

Expect AVXL to rise in stock price into the the close of trading tomorrow!!!

Expect there to be well over a million shares bought tomorrow!!!

Good luck and GOD bless,
👍️0
boi568 boi568 3 hours ago
From what I saw, the now dead Rett complaint read as a press release instead of a legal case. As a legal matter, it was a joke, and its dismissal with prejudice confirms this. But from the beginning, it was a talking point for shorts to use, and later the law firm filing it would at least have been seeking a return on their costs in a settlement with the company. I expect low level shorts will still try to use it against the company in a pathetic attempt to create negative attention.

In the end, Missling refused to settle this as a nuisance case and again sent the message, like he did in 2015 in a similar situation, that he wasn't going to be shaken down. I like that he fights.
🎯 2 👍️ 12 💯 5 😃 3
BDR10 BDR10 3 hours ago
Doesn't triple witching day usually have a lot more volume and what we're seeing?
👋 1 👍️ 1
attilathehunt attilathehunt 3 hours ago
Fuel for thought....

Today is option expiration and most likely the 9 call options will be out of the money by a few cents.

My guess is we close below 9 and open above 9 come Monday morning. Since I believe that, I will exercise my 9 calls if the price is above 8.95 to just piss off the MMs. The above scenario happen in the past so it may occur this time too. Let's see what happens.
👍️ 2
sab63090 sab63090 4 hours ago
Chuck

I could not find the group that put out the analysis:

This was the "bullish outlook" based on the longer term downtrend.....hope it's worth reviewing....I'll see if I can find it in my technical files, but forgot who it was.
👍️ 1
sab63090 sab63090 4 hours ago
Chuck
Follow up:

Analysis of Inverted Hammer in AVXL
Pattern Confirmation:
An Inverted Hammer is a potential bullish reversal signal when it appears after a downtrend. It features a small body, a long upper shadow, and little to no lower shadow, indicating buyers pushed the price up during the session, though sellers brought it back near the open by the close.

For AVXL, you mentioned this pattern was recently observed. Based on the 1-day data from June 20, 2025, AVXL’s price moved from an open of $9.17 to a high of $9.295, a low of $8.686, and closed at $8.982. The intraday high being significantly above the close suggests a long upper shadow, which aligns with an Inverted Hammer if the body is small (close near open). However, the exact candlestick formation would need visual confirmation on a chart, as the data alone doesn’t explicitly confirm the body size.

To confirm the bullish signal, the next trading session should show a strong bullish candle closing above the Inverted Hammer’s high ($9.295). Without access to June 21 data, I can’t confirm this, but your observation suggests the pattern looks bullish, implying follow-through buying may be occurring.
👍️0
BIOChecker4 BIOChecker4 4 hours ago
AVXL down two cents on light volume. Looks like the momentum of the last few trading days has fizzled, as I had predicted.

Repeated spam posting of the 10 year old Ern Heaven video doesn’t seem to be working nor are repeated predictions of imminent great news.
👎️ 1 👺 1
sab63090 sab63090 4 hours ago
John,
Wouldn't it be nice to see him exercise early and keep most of those shares right before approval! Ha ha

Steve (

damn this cold is hanging in since last Thursday....my wife and I just won't get better!!!
👍️0
sab63090 sab63090 4 hours ago
Chuck:

I'm just now almost reaching the top of the posts....

I wish I had a ready reference to show you, but I can find it!

A professional technical group wrote a paper on how inverted candlestick do not have a super strong history especially when they occur at prices close to prior ones! They actually used these to project UPWARD reversal.....I'm not sure if Bulkowski had a write up on this....

Anyway, I think we push UP from here.....Steve
👍️ 1
LakeshoreLeo1953 LakeshoreLeo1953 4 hours ago
First run today at expiry only took about 200K shares to take out $9.
Guess (not including larger settlements MOC)
777K shares and 8,88

How's that for numerology nonsense?
👍️ 1 👎️ 1 👺 1 😃 1
k9uwa k9uwa 4 hours ago
Agree Leo Probably first news for any real increase will be whenever the Clock restarts on the EMA. End of June? July? Aug? Missling has sizable option expire in early Sept. Price was something like $6.76?? It would be to his advantage if price is well up above those numbers for a cashless transaction. schizo test results if a real block buster... sometime this fall? And of course whenever the EMA approves. That might be as far out as Febish I guess. You should get your shot for a few bites along the way.

John k9uwa
👍️ 2
sab63090 sab63090 4 hours ago
kund
To win a legal case is certainly proof that Missling was correct and went forward with his EMA filing...

The case is closed; the judge threw it in the waste basket....several here had posted it as "proof" that Missling lied about the RETT results, yet it's still listed as active!

Although I have been sick, I don't think I've missed too much.....price continues to show strong momentum UP, RSI is at the same level as when we traded at $10 in May and almost as high as when we traded at appx $10.50.....the RSI is in a strong reading now, above 50+....MACD is confirming the trend, the OBV is turning strong with the Weekly Reading solid as gold.........the Weekly Bollinger is push up from the touch at the lower end.....

https://finviz.com/quote.ashx?t=AVXL&ty=c&ta=1&p=w
👍️ 4 😃 3
Citrati Citrati 4 hours ago
A visual to point out why chartists are wary of a top and regroup here besides just the current resistance battle from 9-9.25ish.
Candlestick (inverted hammer) Wed is just like last two and other tops for AVXL.

https://investorshub.advfn.com/uimage/uploads/2025/6/20/vyjsnScreen_Shot_2025-06-20_at_9.35.35_AM.png
👍️ 2
LakeshoreLeo1953 LakeshoreLeo1953 5 hours ago
Forces will make a run @ 8.75. IF that feels safe to them
then watch out below.
There really is NO buy side interest.
I doubt a full retrace (at least today),
but under 8.50 may well be in play setting up next week.
👎️ 1 👺 1
mike_dotcom mike_dotcom 5 hours ago
Hopefully we won't give up all the week's gains today. The stock still falls apart on 40,000 shares traded.
👍️0
LakeshoreLeo1953 LakeshoreLeo1953 5 hours ago
Georgeii
You seem to have fans who do not like

Great CEOs delegate, communicate, and do not obfuscate.

Is it just a generation (or two) that fails to understand accountability?
👎️ 1 👺 1
LakeshoreLeo1953 LakeshoreLeo1953 5 hours ago
Chelsea in Club WC noon Eastern.....

I've "missed" a bit more than $1, but still feel no urgency.
👎️ 1 👺 1
k9uwa k9uwa 5 hours ago
" 90K share buy to start the day" At one hour into the day 180K total. Looks like the shorts are trying dropped +20 to -11 cents. So now guess the shorts or MM's are taking their shot at us.Think a fair number of 8 calls. Guess not many of us around today.

now Last price x size / Exch $8.96 x 200 P down- 0.0700down (-0.78%) Bid x size $8.95 x 100 Q Ask x size $8.97 x 300 Volume 212.67K

I don't see them pushing it all the way to 8. if they start getting close hell I'll buy a little more. Won't be around for close... Golf Course..
John k9uwa
👍️ 2
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 6 hours ago
Nice 90K share buy to start the day
anyone here?
🏆️ 4 👍️ 6 😃 2
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 6 hours ago
Testing 1 2 3 Testing

I always thought if there was major manipulation going on that it would go both ways.
$15 anyone?
Volatility is the lifeblood of trading
👍️ 2 😃 1
ignatiusrielly35 ignatiusrielly35 14 hours ago
God bless
👍️ 2
georgejjl georgejjl 14 hours ago


Good luck and GOD bless,
👍️0
rx7171 rx7171 14 hours ago
“lack of evidence of long term effectiveness”
Another plus for Blarcamasine with its four years of clinical proof of “long term effectiveness”.
👍️ 11
georgejjl georgejjl 17 hours ago
Expect AVXL to rise in stock price into the the close of trading tomorrow!!!

Expect there to be well over a million shares bought tomorrow!!!

Good luck and GOD bless,
👍️0
bb8675309 bb8675309 17 hours ago
Your right, power. Biochecker4 and Kund were both big SAVA supports working that pump up to $120 a share in this fair and balanced market. Probably shorted at the top too. imo
👍️ 9
powerwalker powerwalker 17 hours ago
Were you not one of those that professed how great the SAVA ex-CEO was because he knew the right way to manage a pre-revenue biotech company with "transparency" towards the shareholders, especially at $120+/share ... while never questioning the compensation structure that was based on how high the SP went?

So, forgive me if I and many others on this board take your thoughts about CEO's with a grain of salt ... or make it a pound for me.
👋 4 👍️ 23 😃 1 🤣 3
skitahoe skitahoe 19 hours ago
I've yet to see a biotech company where some investors weren't highly critical of the CEO's. If successful the CEO's are hero's, if they fail, it's all their fault, in reality, they succeed or fail more based on the staff of people and science they're working with more than their own personal talent.

From what I've read Missling has AVXL well positioned to succeed, they're in good financial shape and have numerous shots at success in serious diseases. I believe the greatest proof is measurable, it's the reduction in the rate of brain shrinkage. While it's a normal phenomenon in all of us, it could be of benefit for everyone in their senior years, but clearly it's also accelerated in people with diseases like Alzheimer's. Will everyone be taking one of our products in a decade or two, at my age it's doubtful I'll be here to know, but I think it's possible, but first it will go to those with discernable disease.

CEO's can come and go, if the science is good, success is very likely regardless of who the CEO is. Some CEO's, on the other hand, may navigate a minefield in reaching approvals that others would have failed in, but even those CEO's rarely receive proper credit, at least not from all investors. At the Analyst's targets over $40 most will be complimentary of Missling, at $100 or more he'll be the toast of the town if he's still the CEO.

Gary
👍️ 23 💯 1 😃 1 🧠 1 🫡 1
BIOChecker4 BIOChecker4 20 hours ago
Luckily, people’s memories of your failed predictions haven’t faded.
👍 1 👎️ 2 👺 1 😂 1
BIOChecker4 BIOChecker4 20 hours ago
I listen to you and all I hear is desperation.
👍 1 👎️ 1 👺 1 🔥 1
BIOChecker4 BIOChecker4 20 hours ago
I think it’s obvious that Anavex’s credibility has been hurt by Missling’s fumbles, stumbles, goal-post moving, lack of transparency, stock promotion schemes, terrible communications, and use of ATMs to fund the company over many years. Of course there is no such thing as a perfect CEO. CEOs are human and make mistakes. I don’t expect Missling to be perfect. But there’s a difference between great CEOs who are credible in the eyes of professional biotech investors who occasionally make mistakes and a perceived buffoon who can’t put a simple sentence together without causing confusion.

Take some time to look back over the years at Missling’s track record. Everything is online. Yes, he got the MAA filed. If Blarcamesine gets approved, all will be forgiven. But it’s a fact that there are reasons to be concerned, particularly since no large-scale phase 3 trials have been done. I think it’s possible he’s thrown a hail-Mary pass simply because that’s the last shot at success for years to come.

I do hope to be wrong.
👍️ 1 👎️ 3 👺 1
blue Hawaii blue Hawaii 20 hours ago
i read that quantum computers can now help solve protein misfolding problems with up to 12 amino acidsmost everand and fastest ever
maybe this company can use quantum computing to their benefit
👍️ 5
LakeshoreLeo1953 LakeshoreLeo1953 21 hours ago
Great CEOs delegate, communicate, and do not obfuscate.
Against that scorecard, each here is free to grade Missling.
As to the serendipity that a Company survives blunders…..Rather be Lucky

AND GOOD if I can get it.
👎️ 3 👺 2
kund kund 22 hours ago
Misleading just got another pass to pull new endpoints out his arse.
👎️ 5 👺 3 🦶 1 🧻 1
ignatiusrielly35 ignatiusrielly35 22 hours ago
I put a 9+ close at about 5%. They will make a run at the 8's also but it's too far. 
👎️ 1 👺 1
skitahoe skitahoe 22 hours ago
I'm not a big subscriber of the Max Pain theory at option expiration, but with where we are, $9 is a pretty logical close tomorrow, unless it runs up near $10. I don't believe it will fall toward $8.

For anyone who has sold $9 calls tomorrow could be nervous times unless you repurchase them early in the day. As someone who's sold covered calls before, I hate losing share from a stock selling a few cents above my price, nor do I like converting such shares.

Gary
👍️ 2
Citrati Citrati 23 hours ago
For those who might not know, "with prejudice" means permanently dismissed. It cannot be refiled using any of the adjudicated claims.
👍️ 13 👏 1 💯 1
Citrati Citrati 23 hours ago
The behind the scenes enthusiasm is manifest in the percent of retail ownership. One thing that can account for low volume would be the vast majority of current retail as Long Term holders combined with the so far steadiness of institutions.

AI Overview
Retail investors own approximately 59% of Anavex Life Sciences Corp. (AVXL) stock. This means that individual investors, as opposed to institutional investors like mutual funds or hedge funds, hold the majority of the company's shares, according to finance websites. Institutional investors hold around 38% of the shares.
Here's a more detailed breakdown:
Retail Investors: 59%
Institutional Investors: 38%
Insider Ownership: 5.15%
Anavex Life Sciences: A Promotional Company With Too Many ...
While the exact percentage can fluctuate, these figures indicate that retail investors have a significant influence on the stock's price and movement.
👍️ 4

Your Recent History

NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads